Lavendustin C, a derivative of a Streptomyces griseolavendus butyl acetate extract, is a potent inhibitor of epidermal growth factor (EGF) receptor-associated tyrosine kinase with an IC value of 0.012 µM. Lavendustin C also inhibits pp60 kinase and Ca calmodulin-dependent kinase II with IC values of 0.5 and 0.2 µM, respectively. At a concentration of 10-150 µM, lavendustin C inhibits tyrosine kinase-associated neutrophil degranulation and superoxide generation.
Lavendustin C is a potent Ca2+ calmodulin-dependent kinase II (CaMK II) inhibitor with an IC50 of 0.2 μM. Lavendustin C inhibits EGFR-associated tyrosine kinase (IC50=0.012 μM) and pp60c-src(+) kinase (IC50=0.5 μM) [1][2].
IC50&Target
CaMK II EGFR
0.2 μM (IC50) 0.012 μM (IC50)
体外研究
Lavendustin C shows potent inhibitory activity, and it may be the core structure responsible for inhibition of tyrosine kinase[1].
Lavendustin C (10-150 μM) inhibits tyrosine kinase-associated neutrophil degranulation and superoxide generation.
分子式
C14H13NO5
分子量
275.26
CAS号
125697-93-0
中文名称
薰衣草素C
运输条件
Room temperature in continental US; may vary elsewhere.
[1]. T Onoda, et al.Isolation of a Novel Tyrosine Kinase Inhibitor, Lavendustin A, From Streptomyces Griseolavendus. J Nat Prod. Nov-Dec 1989;52(6):1252-7.
[2]. T J O'Dell, et al.Long-term Potentiation in the Hippocampus Is Blocked by Tyrosine Kinase Inhibitors. Nature. 1991 Oct 10;353(6344):558-60.